Market revenue in 2022 | USD 52.7 million |
Market revenue in 2030 | USD 604.7 million |
Growth rate | 35.7% (CAGR from 2022 to 2030) |
Largest segment | Deep learning |
Fastest growing segment | Natural language processing |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Deep Learning, Querying Method, Natural language processing, Context aware processing |
Key market players worldwide | BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in precision medicine market will help companies and investors design strategic landscapes.
Deep learning was the largest segment with a revenue share of 33.59% in 2022. Horizon Databook has segmented the France artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2017 to 2030.
The growing development of new technologies, such as AI, and their widespread use across a variety of sectors have raised the demand for AI in precision medicine. The market for AI in precision medicine is expanding globally because of the growing need to reduce costs and improve operational efficiency in drug discovery and clinical trials.
For example, in February 2022, the Jean Perrin Center at the Clermont-Ferrand University Hospital in France announced a partnership with Illumina, Inc. to examine the clinical benefits of comprehensive genomic profiling in cancer therapy options for patients.
The French healthcare system will adopt a precision medicine strategy for patients with late-stage cancer based on data from the CELIA (complete genomic profile impact) research project.
Horizon Databook provides a detailed overview of country-level data and insights on the France artificial intelligence in precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into France artificial intelligence in precision medicine market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account